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Noninvasive criteria developed in a learning series for
exercise-enhanced risk assessment for events due to coro-
nary heart disease have been applied to a test series in
a later population sample. Men in the same age and risk
groups for each pretest clinical classification show sim-
Prior studies of the Seattle Heart Watch indicated the fea-
sibility of symptom-limited maximal exercise testing by the
Bruce protocol (1) in routine clinical practice (2). Effects
of hypertension and coronary heart disease were separated
from the concomitant physiologic consequences of aging
(3). Clinical and noninvasive exercise predictors of sudden
cardiac death have been identified (4), and the potential for
noninvasive screening of patients with coronary heart dis-
ease for longer survival after coronary bypass surgery has
been reported (5). Results of exercise-enhanced risk as-
sessments of primary coronary heart disease events in healthy
men (6), men with hypertension (7) and men with atypical
chest pain syndromes (8) as well as the amount of risk
enhancement (9) have been reported. (Two errors in that
report should be corrected. The cumulative 5 year incidence
rate in hypertensive men should be 18.2% rather than 33.3%
as reported in the abstract, and survival rate without primary
events in hypertensive men should be 81.8 ± 3.2%, as
stated on page 570 of the text.) Furthermore, a pilot study
(10) indicates that such testing motivates many individuals
to modify risk factors.
The present study tests the hypothesis that criteria for
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i1ar gradients of risk. Thus, exercise-enhanced criteria
for risk assessment are validated. Age-standardized event
rates show a reduction longitudinally in healthy men and
patients who have had coronary bypass surgery.
(J Am Coil CardioI1985;5:875-81)
exercise-enhanced risk assessment for coronary heart dis-
ease events are valid when applied to follow-up of a later
population sample of men examined and tested noninva-
sively by physicians in Seattle community practice. Because
of a reported 34% decrease in mortality due to coronary
heart disease in the state of Washington, which exceeds the
decrease in other states (11), longitudinal changes in mor-
tality rates are also examined.
Methods
Study population. Salient clinical risk factor and ex-
ercise responses at enrollment, and subsequent follow-up
findings in 5,308 men enrolled in the learning series of the
Seattle Heart Watch during 1971 to 1974 are compared with
findings in 3,065 other men enrolled in the test series* from
1975 to 1981 (12). Each year the institutional human sub-
jects review committee reviewed and approved the study
protocol and informed written consent forms of the subjects.
Of the 8,373 men, 4,105 (49%) were classified before
exercise testing as asymptomatic healthy individuals. The
majority of these healthy men were from an industrial cohort
and were voluntarily examined annually because of cor-
porate policy; the remainder had presented to their physi-
cians for a health assessment as described previously (6).
Another 1,374 men had hypertension and 2,894 had prior
*The "test series" were men examined and exercised in an identical
manner to the original participants in the Seattle Heart Watch Study. The
same groups of physicians participated and initial clinical classification
and subsequent classification of events were similar to those of the Seattle
Heart Watch Study.
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clinical manifestations of coronary heart disease. The latter
included typical angina pectoris, myocardial infarction, car-
diac arrest or cardiac death. Almost all were white, urban
and predominantly middle class persons.
Classification of risk. Risk was characterized as "low,"
"increased" or "high" for men free of clinical evidence
of coronary heart disease. Low risk was defined by the
absence of all conventional risk factors, as listed in Table
1. Increased risk was defined by the presence of any con-
ventional risk factor and fewer than two exercise predictors
for healthy men. Any conventional risk factor or exercise
predictor indicated increased risk in hypertensive men. High
risk was defined by the combination of one or more con-
ventional risk factors and two or more exercise predictors
in healthy men (6). In hypertensive men, high risk was
defined by the combination of any risk factor and any ex-
ercise predictor. In men with coronary heart disease, risk
was assessed by the pathophysiologic syndromes listed in
Table I.
Follow-up. Subsequent primary or secondary events due
to coronary heart disease were ascertained periodically by
Table 1. Criteria for Exercise-Enhanced Risk Assessments
questionnaires mailed to each individual. Funding to as-
certain the role of vasectomy as a risk factor (13) provided
only a single questionnaire follow-up in the test series in
1980 to 1981. This also included questions about any in-
terventions to alter remediable risk factors (10).
Criteria for coronary events. The criteria for morbidity
due to coronary heart disease have consistently been hospital
admission for angina pectoris, coronary artery bypass sur-
gery, acute myocardial infarction or sudden cardiac arrest
with resuscitation by ventricular defibrillation (4-9). Car-
diac mortality was classified as sudden when death occurred
within 24 hours of symptoms, nonsudden if it occurred after
the first day of symptoms or procedural if it was related to
cardiac catheterization or cardiac surgery. (No deaths were
reported in relation to exercise testing.) Information about
the timing and circumstances of death was usually obtained
from narrative descriptions from the next of kin to supple-
ment medical records and death reports. Three cardiologists
independently reviewed the data to classify these events.
Primary coronary events included all admissions to the
hospital for the previously mentioned reasons. Secondary
Clinical Classification
I. Healthy men (no symptoms, signs or
treatment of cardiovascular disease)
II. Hypertensive men (history of prior
hypertension without coronary heart
disease, usually treated, or discovery
of systolic blood pressure of 2:140
mm Hg)
III. Coronary heart disease (history of angina
pectoris, myocardial infarction and/or
sudden cardiac arrest from ventricular
arrhythmia, with or without
hypertension)
Conventional Risk Factors
1. Family history of myocardial infarction
and/or sudden cardiac death in
parents and/or siblings
2. Hypertension (systolic pressure of
2:140 mm Hg)
3. Hypercholesterolemia
(total cholesterol of 2:250 mg/dl*)
4. Cigarette smoking
I. Family history as stated for healthy
men
2. Hypercholesterolemia
3. Cigarette smoking
4. Risk factor count
I. None contribute significantly to
prediction
Exercise Risk Predictors
I. Chest pain during maximal exercise testing
2. Exercise duration <6 minutes or <stage
III (of Bruce protocol)
3. Maximal heart rate <90% of age-predicted
average normal value
4. ST segment depression of 2:1 mm,
horizontal or downsloping for at least I
minute or, if upsloping, for 3 minutes
I. Chest pain during maximal exercise testing
2. Functional aerobic impairment of 2:25%
which adjusts duration for age
3. Maximal heart rate <80% of age-predicted
average normal value
4. Exercise predictor count
Pathophysiologic Syndromes
I. Exertional myocardial ischemia
a. Chest pain during exercise testing
b. ST segment depression of 2:1 mm
usually beginning at submaximal
work loads, increasing in
magnitude at maximal exercise and
evolving over several minutes in
recovery
2. Left ventricular dysfunction:
a. Cardiomegaly on examination
b. Exercise duration <3 minutes or
<Stage II, and/or
c. Peak systolic pressure during exercise
<130 mm Hg
3. Both syndromes
4. Neither syndrome
*In healthy men without cholesterol determinations, the incidence of coronary events did not exceed that for men without hypercholesterolemia (6).
The same trend is observed in healthy men in the test series, of whom 564 had no reported cholesterol levels.
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events were restricted to " hard" spontaneous events due to
myocardial infarction, cardiac arrest or cardiac death Hos-
pital admissions for arteriographic evaluation or surgical
treatment , or both, of angina pectoris were excluded because
some were prompted by the patients' response to exercise
testing.
Statistical methods. Variations in distribution of dis-
crete variables were compared between groups using chi-
square analysis for contingency tables . The occurrence of
a first event was compared among groups using the life table
method and the log rank test. The significance of longitu-
dinal changes in age-standardized incidence of subsequent
coronary events was computed by adjusting for three age
intervals «45, 45 to 54, 2::55 years) within each clinical
classification and enhanced risk assessment group. The sum
of combined registry populations (n = 8,373) was used as
the reference group.
Results
Distribution of men at enrollment. Within each clin-
ical classification, the distribution of men in the test series
versus the learning series shows significant differences in
relation to age and exercise-enhanced risk assessments (Ta-
ble 2). There are more older men and more men at low risk
among the healthy men in the test series. Yet the small
proportion (1. 1%) of healthy men at high risk is identical
with the proportion in the learning series. Among hyper-
tensive men, more are older and also at high risk. Whereas
age differences are more significant than risk differences in
healthy and hypertensive men, differences in distribution
according to pathophysiologic syndromes are more signif-
icant than age differences in patients with coronary heart
disease whether or not they have had coronary bypass surgery.
Variations in incidence of coronary heart disease
events. The age-specific incidences of all primary and only
"hard" secondary events due to coronary heart disease in
relation to clinical classifications and risk categories are
detailed elsewhere* . Comparison of these rates in the test
series with those of the learning series reveals no statistically
significant differences. Thus, the similarity of the risk gra-
dients validates the criteria for exercise -enhanced coronary
risk assessments in healthy men, hypertensive patients and
nonsurgically treated patients with coronary heart disease .
Inasmuch as several risk categories of patients with coronary
heart disease who have had coronary bypass surgery do not,
as yet, reveal any late morbidity or mortality, this treatment
biases evaluation of the risk gradient.
Longitudinal changes in age-standardized incidence
of coronary events. To adjust for differences in age dis-
*Dala on file as NAPS Document no . 04620 for three pages of sup-
plementary materials from ASIStNAPS, Microfiche Publications, P.O.
Box 3513, Grand Central Station, New York, New York 10163.
tribution of men enrolled in the test series, age-standardized
incidence was calculated for each risk group and clinical
classification (Table 3) . Three conclusions are apparent:
I) Lower event rates are observed in the test series in
healthy men, in hypertensive men not at high risk and in
men with coronary heart disease with either or both patho-
logic syndromes.
2) With the exception of healthy men at low risk and
surgically treated men with coronary disease with these syn-
dromes preoperatively, substantial and roughly similar mor-
tality rates are found in all categories in the test series of
men.
3) There is a reasonable question whether interventions
may account for the reductions in incidence. More effective
medical treatment and coronary bypass surgery, once path-
ophysiologic impairment is recognized, may be contributory
in the patients, but these interventions do not fully account
for changes in the healthy men.
Risk factor intervention in healthy men. Among 1,086
healthy men with one or more conventional risk factors,
half (50.7%) reported one or more interventions. These
included cessation of smoking , reduced ingestion of fat,
loss of weight, increase of exercise and treatment of high
blood pressure. (Details about date of onset of intervention,
amount , duration and adherence are not available .) Eight
events occurred in men reporting no intervention, including
angina in two men (one with coronary bypass surgery) myo-
cardial infarctions in two and cardiac deaths in four men
aged 43 to 65 years. Six men were at increased risk with
50% case mortality, and two were at high risk with 50%
case mortality. Only three events (angina) occurred in men
of 42 to 54 years of age who reported any intervention . All
three men were at increased risk and two of these had coro-
nary bypass surgery; no deaths were reported. The annual
incidence of these primary events was 0.52% for the non-
intervention group and 0.19% for the intervention group.
The first event in the latter group did not occur until 3 years
had elapsed; when cumulative incidence was evaluated by
life-table method, a log-rank statistic of 5.3 (with 2 degrees
of freedom) indicated a significant decrease (p < 0.05) .
Similar analyses of patients with hypertension and coro-
nary heart disease did not reveal any effect of risk factor
intervention.
Discussion
Significant findings. The results obtained in the test se-
ries indicate similar risk gradients for coronary heart disease
events as reported earlier in healthy men and men with
hypertension and coronary artery disease who are initially
classified clinically and evaluated by risk factor, exercise
risk predictors or pathophysiologic syndromes. Although
risk of events increases with age and severity of cardiovas-
cular impairment, age-specific incidences revealed no sig-
nificant differences in all categories that could be evaluated.
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Table 2. Variations in Distributions of Men
Learning Series Test Series
Registry n (%) n (%)
Healthy
Age (yr)
< 45 1,197 (50.6) 84 \ (48.3) ¥ = 56.\
45 to 54 926 (39.2) 583 (33.5) 2 df
;::,55 242 (10.2) 316 (18.2) P < 0.001
Risk
Low 980 (41.4) 802 (46.1) ¥ = 8.98
Increased 1,360 (57.5) 9 \9 (52.8) 2 df
High 25 (1.1) \9 (1.1) P < 0.025
Hypertensive
Age (yr)
<45 2\4 (30.3) \62 (24.3) ¥ = 22.42
45 to 54 297 (42.0) 240 (36.0) 2 df
;::,55 \96 (27.7) 265 (39.7) P < 0.01
Risk
Low 200 (28.3) \86 (27.9) ¥ = 6.84
Increased 398 (56.3) 343 (51.4) 2 df
High 109 (15.4) 138 (20.7) P < 0.05
Nonsurgically Treated Coronary Heart Disease
Age (yr)
< 45 242 (15.6) 55( 11.2) ¥ = 23.49
45 to 54 643 (41.4) \63 (33.3) 2 df
;::,55 670 (43. I) 272 (55.5) P < 0.0 \
Syndromes
Neither 597 (38.4) 234 (47.8) ¥ = 73.68
Myocardial ischemia 62 1 (39.9) 101 (20.6) 2 df
LV dysfunction 117 (7.5) 75 (15.3) P < 0.001
Both 220 (14. \) 80 (16.3)
Surgically Treated Coronary Heart Disease
Age (yr)
<45 105 (15.4) \6 (9.5) X2 = 23.85
45 to 54 3\6 (46.4) 53 (31.5) 2 df
;::,55 260 (38.2) 99 (58.9) P < 0.01
Syndromes
Neither 104 (15.3) 50 (29.8) ¥ = 61.65
Myocardial ischemia 382 (56.1) 43 (25.6) 2 df
LV dysfunction \7 (2.5) 16 (9.5) p < 0.00 \
Both 178 (26. 1) 59 (35. \)
Total 5,308 (63.4) + 3,065 (36.6) 8,373 (100.0)
df = degrees of freedom; LV = left ventricular; n = number of men.
Thus, the criteria for exercise-enhanced risk assessment are
considered validated. The report by Hopkirk et al. (14) also
indicates the utility of sequential risk factors and exercise
factors in the evaluation of normal subjects to identify in-
dividuals with significant coronary artery disease.
Despite significant differences in age and risk distribu-
tions , the age-standardized incidence of primary coronary
events was lower in the test series except in hypertensive
men at high risk. Age-standardized incidence of "hard"
secondary events (that is, myocardial infarction and cardiac
death) was lower in men with coronary heart disease who
manifested exertional myocardial ischemia or noninvasive
criteria (before any invasive data were available) of left
ventricular dysfunction . Indeed , such patients who had coro-
nary bypass surgery reported no morbidity or mortality up
to the time of follow-up. More effective medical and surgical
treatment may contribute to the apparent reduction in the
incidence of secondary events. Exceptions to this trend are
hypertensive patients at high risk and patients with coronary
heart disease without these pathophysiologic syndromes.
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Table 3. Age-Standardized Incidence of Coronary Events and Percent Mortality Rates*
% Mortality Rates
Classification Risk Group
Incidence (n, %/yr)
Learning Series Test Series
Learnin g
Series
Test
Series
Healthy
Hypertension
All Primary Events in Men Without Coronary Heart Disease
Low 18 0 .39 3 0.21 15.3 0.0
Increa sed 43 0 .54 9 0 .23 12.1 41. 0
High 8 5.73 2 2.05 4 1.0 50 .0
Low I I 0 .77 4 0.50 9. 1 50 .0
Increased 42 2.78 20 2.06 45 .0 23.3
High 26 3.7 1 19 4 .51 42.0 35 .6
" Hard" Secondary Events in Men With Coronary Heart Disease
Nonsurgically treated
Neither 14 3.0 1 17 3.04 56. 5 73 .7
Myoc ardial ischemia 133 3.74 6 1.50 59 .5 75.3
LV dysfunct ion 43 10.36 20 8.58 77. 1 82 .9
Both 88 13.01 27 10.44 69 .9 96.6
Surgically treated
Neither 4 0 .79 3 2.42 45.6 37. 1
Myocardi al ischemia 43 5.70 0 0 .00 49 .3 0 .0
LV dysfunc tion 4 7.45 0 0 .00 20 . 1 0 .0
Both 13 1.93 0 0 .00 82 .4 0.0
*To adjust for significant differences in age distributions of all clinical groups defined in Table 1.
men at high risk is provocative. Th is suggests that strategies
for improving prognosis of hypertensive men might be
reevaluated .
Figure 1. Longitudinalchanges in age-standardizedincidence of
primary coronaryheart disease (CHD) events in healthy men strat-
ifiedaccording to initial risk assessment. Morbidity(MORB.) rates
are separated from mortality (MORT.) rates; incidence rates for
the learning series are shown on the left and incidence rates for
the test series are shown on the right . Note the substantial reduc-
tions in both morbidity and mortality. INCR. = increased.
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Whether the former group was overtreated or the latter group
was treated prematurely cannot be ascertained from these
data .
There is a provocative suggestion , however, in healthy
men with risk factors that risk factor intervention may be
effective in preventing primary coronary events. Only pro-
longed follow -up will reveal whether this effect merely post-
pones the occurrence of coronary events . Neither the initial
classification of an active physical status nor the subsequent
respon se to the questionnaire in regard to increased exercise
revealed a statistically significant difference in incidence of
coronary events.
Interaction of selection of a higher proportion of health y
men at low risk , despite a larger fract ion of older men , and
alleged interventions against remediable risk factors may
account for the reduction in incidence of primary events in
health y men . Although this Irend is con sistent with a re-
ported 34% decrease in mortalit y from coronary heart dis-
ease in the State of Washington ( I I), this statewide decrease
reflects primarily mortality from secondary coronary events
in patients with known coronary heart disease . Thus, the
observed reduction in the number of patient s Ireated med-
ically or surgically is more likely to correlate with the state-
wide decrease in mortality ,
Despite some decrease in the incidence of secondary
events in patients with coronary disease, the apparent failure
to observe a similar change in primary events in hypertensive
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Figure 2. Longitudinal changes in age-standardized incidence of
primary coronary heart disease events in hypertensive men strat-
ifiedaccording to initialriskassessment. Morbidity (MORB.)rates
are separated from mortality (MORT.) rates; incidence rates for
the learning series are shown on the left and incidence rates for
the test seriesare shownon the right. Note similarity of morbidity
and mortality rates in test and learningseries; see text for details.
Limitations of this study. Methodologic limitations
should be noted. The majority of physicians failed to report
serum cholesterol levels in all clinical categories. Yet the
incidence of coronary events was always insignificantly lower
in healthy men, hypertensive men and men with coronary
heart disease in the test series. Thus, any loss of predictive
Figure 3. Longitudinal changes in age-standardized incidence of
hard secondary events due to coronary heart disease in men with
coronary heart disease who remain without surgical treatment.
Theyare stratified in relationto pathophysiologic syndromes: myo-
cardial ischemia(MYOC. ISCH.) and left ventricular dysfunction
(LV DYSFUNC). Morbidity (MORB.) rates are separated from
mortality (MORT.) rates; incidence rates for the learning series
are shown on the left and incidence rates for the test series are
shown on the right. Note the substantial reduction in morbidity.
Note that mortality rate exceeds morbidity rate.
We are indebted to numerous subjects, patients, physicians and data man-
agers, particularly Verona Hofer, BS, who participated in these studies.
The helpful critiques of Harold T. Dodge, MD and George N. Aagaard,
MD are also acknowledged.
I. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nom-
ographic assessment of function aerobic impairment in cardiovascular
disease. Am Heart J 1973;85:546-62.
References
value by this omission could not be established. Electro-
cardiographic monitoring may beconsidered suboptimal when
only a single bipolar precordial lead was monitored contin-
uously. Three considerations are noteworthy in this respect.
An earlier study (15) involving computer averaging and
quantitative analysis indicated that the information content
of this lead closely approximated that of Frank orthogonal
X, Y, Z leads. Only a single lead was commonly used in
clinical practice during the early years of the study, and
only a single lead could be transmitted by dataphone for
independent computer analysis. Evaluation of more than
3,800 persons indicated that maximal differentiation of the
ST response of patients with coronary heart disease from
that of normal subjects occurred 1 minute after maximal
exercise (p < 0.00(02) (16).
Medical treatment could be a confounding variable. This
data base was limited to drug treatment at the time of en-
rollment; subsequent variations in onset, amount, adherence
to and duration of drug treatment over several years could
not be ascertained. Of interest, the initial study (7) of hy-
pertensive men reported an incidence of coronary events in
23.211,000 man-years in treated versus only 13.211,000 man-
years for untreated patients (NS). The original aim of these
studies was evaluation of responses to noninvasive exercise
testing in addition to medical assessment of ambulatory
persons in community practice. Another study involving
appropriate experimental design (17) has applied serial ex-
ercise testing to evaluate the effects of prolonged treatment
rather than predictive value of the initial exercise test.
Clinical implications. Symptom-limited maximal ex-
ercise testing for risk assessment for coronary heart disease
events is useful in healthy men with one or more conven-
tional risk factors, hypertensive men and ambulatory pa-
tients with coronary heart disease. Although criteria for
exercise-enhanced risk assessment are not identical for all
clinical categories, some individuals at high risk can be
identified. When this sequential evaluation identifies men
at high risk, further diagnostic studies and treatment are
warranted. Nevertheless, the majority of events occur in
men with only increased rather than high risk. Because of
the provocative evidence for a reduction in incidence of
coronary events in those who report risk factor intervention,
more emphasis on intervention and, when indicated, med-
ical treatment is warranted, whether or not exercise testing
is performed to identify men at high risk.
LV llll'1ll
• DVSFlM: lO0OI'BOTH·MYOC lSCH- NEITHER
• LOW R • • INCR RISK~ • HIGH RISK
B.
6.
P 11.
E
R
C
E
N
T
I
y
E
A
R
P
E
R
C
E
N
T
I
Y
E
A
R
lACC Vol. 5, No.4
April 1985:875-81
BRUCE ET AL.
EXERCISE-ENHANCED RISK ASSESSMENT
881
2. Bruce RA, Gey GO, Cooper MN, Fisher LD, Peterson DR. Seattle
Heart Watch: initial clinical, circulatory and electrocardiograpic re-
sponses to maximal exercise. Am J Cardiol 1974;33:459-69.
3. Bruce RA, Fisher LD, Cooper MN, Gey GO. Separation of effects
of cardiovascular disease and age on ventricular function with maximal
exercise. Am J Cardiol 1974;34:754-63.
4. Bruce RA, DeRouen TA, Peterson DR, et al. Non-invasive predictors
of sudden cardiac death in men with coronary disease. Am J Cardiol
1970;39:833-40.
5. Bruce RA, DeRouen TA, Hammermeister KE. Non-invasive screen-
ing criteria for enhanced 4-year survival after aortocoronary bypass
surgery. Circulation 1979;60:638-46.
6. Bruce RA, DeRouen TA, Hossack KF. Value of maximal exercise
tests in risk assessment of primary coronary heart disease events in
healthy men from five years' experience of the Seattle Heart Watch
Study. Am J Cardiol 1980;46:371-8.
7. Hossack KF, Bruce RA, DeRouen TA. Evaluation of hypertensive
males for primary coronary heart disease events using conventional
risk factors and maximal exercise testing. Clin Cardiol 1980;3:229-35.
8. Hossack KF, Bruce RA, Fisher LD, Hofer V. Prognostic value of
risk factors and exercise testing in men with atypical chest pain. Intern
J Cardiol 1983;3:37-50.
9. Bruce RA, Hossack KF, DeRouen TA, Hofer V. Enhanced risk as-
sessment for primary coronary heart disease events by maximal ex-
ercise testing: 10 years' experience of Seattle Heart Watch. J Am Coli
Cardiol 1984;2:565-73.
10. Bruce RA, DeRouen TA, Hossack KF. Pilot study examining the
motivational efforts of maximal exercise testing to modify risk factors
and health habits. Cardiology 1980;66:111-9.
II. Leaverton PE, Feinlaub M, Thom T. Coronary heart disease mortality
in U.S. blacks, 1968-1978. Interstate variation. Am Heart J 1984;
108:732-7.
12. Bruce RA, Hossack KF, Belanger L, et al. A computer terminal
program to evaluate cardiovascular functional limits and estimate coro-
nary event risks. West J Med 1981;35:342-50.
13. Perrin EB, Woods JS, Namchata T, Yagi J, Bruce RA, Hofer V.
Long-term effect of vasectomy on coronary heart disease. Am J Public
Health 1984;74:128-32.
14. Hopkirk JAC, Uhl GS, Hickman JR, Fisher J, Medina A. Discriminant
value of clinical and exercise variables in detecting significant coronary
artery disease in asymptomatic men. J Am Call Cardiol 1984;3:887-94.
15. Homsten TR, Bruce RA. Computer ST forces of Frank and bipolar
exercise electrocardiograms. Am Heart J 1969;78:346-57.
16. Bruce RA. Computer analysis of ECG responses to maximal exercise.
In: Tolan GO, Pryor TA, eds. Proceedings of 1980 Engineering Foun-
dation Conference: Computerized Interpretation of the Electrocardio-
gram, New York: Engineering Foundation, 1980:19-133.
17. Hossack KF, Kannagi T, Day B, Bruce RA: Long-term study of high-
dose diltiazem in chronic stable angina. Am Heart J 1984;107:1215-20.
